SECURITIES AND EXCHANGE COMMISSION
                        
             Washington, D.C.  20549
                        
                        
                    FORM 8-K
                        
                 CURRENT REPORT
                        
     Pursuant to Section 13 or 15(d) of the
         Securities Exchange Act of 1934
                        
Date of Report (Date of earliest event reported): October 2, 1995
                        
                        
                        
IMMUNOMEDICS, INC.                  
(Exact name of registrant as specified in its charter)
                        
                        
                        
Delaware                        0-12104             61-1009366
(State or Other Jurisdiction    (Commission         (IRS Employer
of Incorporation)               File Number)        Identification No.)



300 American Road, Morris Plains, New Jersey            07950
(Address of principal executive offices)              (Zip Code)



Registrant's telephone number, including area code: (201) 605-8200




(Former name or former address, if changed since last report)
                        
                        


Item 5.  Other Events

       The information contained in Exhibit 99 is incorporated here 
     by reference.

Item 7.  Financial Statement and Exhibits

     (c) Exhibits

          Exhibit 99 - Press Release, dated October 2, 1995



                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934,
     the Registrant has duly caused this report to be signed on its behalf 
     by the undersigned thereunto duly authorized.
                                                  

                                             IMMUNOMEDICS, INC.


                                             By: /s/ Amy Factor
                                                     Amy Factor
                                                     Executive Vice President


Date: October 2, 1995